EMBL Ventures GmbH

About The Fund

EMBL Ventures GmbH is a venture capital firm that specializes in equity investments within the life sciences sector. Based in Heidelberg, Germany, they are strategically positioned to engage with and support life science companies across Europe. Their investment focus spans various industries including BioTech, Medical Devices (& Hospital Services), Life Science, and Oncology. With assets under management amounting to EUR 120 million, EMBL Ventures aims to foster the growth of companies that have the potential to create significant commercial opportunities through innovative therapeutic treatments, pharmaceuticals, enabling technology platforms, as well as advancements in diagnostics and medical devices. The firm operates on an investment spectrum, offering a minimum of EUR 100,000 and capping at EUR 5 million, targeting stages from Seed to Early Stage companies. EMBL Ventures prides itself on its deep industry and scientific network, a robust track record of investment, and valuable experience in company building, including the facilitation of collaboration and licensing agreements, mergers and acquisitions (M&A), and initial public offerings (IPOs). The companies that engage with EMBL Ventures benefit from more than just capital. They receive committed support, dedicated time and attention, and most importantly, access to EMBL Ventures' extensive network. This includes a unique connection to the European Molecular Biology Laboratory (EMBL), providing significant added value and resources to companies within their portfolio. EMBL Ventures is dedicated to discovering, building, and growing firms with the capacity to transform the life science technology market.